Delivery Order SPE2DB22D2006-SPE2DB25FW2ZC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a brand-name pharmaceutical product used primarily for treating rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,510.60 and is scheduled for completion by July 1, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency has awarded a delivery order valued at $13,635.57 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product used in the treatment of autoimmune conditions. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work from...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA Pen 40 mg/0.8 mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This is a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and was awarded on June 16, 2025, without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,387.94 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a pharmaceutical product for immunological disease treatment. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by November 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $14,131.43 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, an injectable rheumatoid arthritis medication. This firm fixed price, non-set-aside delivery order was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $32,943.62 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and was awarded competitively without a set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,950.67 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 MG/0.4 MLS, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025, and was not subject to a set-aside designation. The contract was issued from AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $5,287.10 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of autoimmune conditions. This non-set-aside, competitively awarded contract features firm fixed price terms with an ultimate completion date of September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. As a major...
- The Defense Logistics Agency awarded a $1,510.60 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic medication used to treat autoimmune conditions. This is a firm fixed-price delivery order with an ultimate completion date of April 24, 2025, issued under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,151.59 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a specialty pharmaceutical product used in the treatment of autoimmune conditions. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025....
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2ZCDelivery Order
The Defense Logistics Agency awarded a $59,112.32 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 31, 2025. The award is issued as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. This prime indefinite delivery vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally in support of military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company has demonstrated substantial capability in fulfilling federal medical supply requirements through multiple competitive awards with the Defense Logistics Agency, providing brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical devices across various therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.1k | 7/30/25 |